Geneva, Switzerland -The Wyss Center for Bio and Neuroengineering, an independent, non-profit, research organization that innovates and accelerates technologies and therapies to transform the lives of people with neurological and mental health disorders, partners with the ALBA Network, to raise awareness and advocate for increased equity, inclusion and visibility of scientists from underrepresented groups in brain research.
“It is very exciting to announce our new partnership with the Wyss Center. We are delighted that this pioneering enterprise focused on using advanced technology to develop new treatments for brain disorders has chosen to provide sustained and critical support for our work on improving diversity and inclusion in the brain sciences, and we look forward to working together on these shared goals.”, says Laura Andreae, Chair of ALBA Network.
With over 1300 members worldwide, the ALBA Network is a growing and highly dynamic movement in the neuroscientific community to foster diversity, equity and inclusion (DEI) in brain sciences. Through the implementation of a broad portfolio of globally-focused DEI activities, the network strives to advocate for actions and policies to counteract bias and build inclusive research cultures. ALBA is administered by FENS, the Federation of European Neuroscience Societies, an international non-profit association that serves as the main organization representing neuroscience in Europe.
"We are thrilled to announce our partnership with the ALBA Network. At the Wyss Center, we are committed to innovating and advancing technologies and therapies developed through research efforts that reflect the diverse experiences and perspectives of the patient populations we aim to serve. By working together with the ALBA Network, we will build a stronger foundation for brain research that embodies diversity, equity and inclusion. ", says Tracy Laabs, Chief Development Officer of the Wyss Center.
The Wyss Center pursues transformational technologies in artificial intelligence, bio- and neuroengineering to restore essential neural functions and deliver precision therapeutics for people with debilitating neurological and mental health disorders. Based at Campus Biotech in Geneva, Switzerland, the Wyss Center partners with faculty, clinicians and industry, in Switzerland and internationally, to drive innovation and maximize clinical impact. The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center achieve its mission.
New project: Synapsuit
Translating arm and hand movement intentions into actionWyss Center
The Wyss Center and partners launch CHF 18 million Lighthouse Partnership to develop smarter therapies for neurologic and mental health disorders based on AI guided neuromodulation
A new model of cooperation and collaboration to accelerate translational research and development in the field of neurotechnology and artificial intelligence.Collaboration
The Wyss Center receives ISO 13485 Certification by TÜV SÜD for its Quality Management SystemWyss Center